“The broad uptake of modern 3D cell culture techniques in biomedical R&D has been slowed down by a lack of easy-to-use and reproducible biomaterials that enable cells to grow and behave in a physiological manner. We are excited to partner with Rousselot Biomedical to overcome these limitations and provide the world’s first, ready-to-use 3D cell culture kits based on Rousselot’s X-Pure GelMA.”
- Dr Christoph Meinert
CEO of Gelomics
Gelomics is pleased to announce a new cobranding agreement with Rousselot effective from October 2022.
The partnership concerns the supply of Rousselot X-Pure® GelMA (gelatin methacryloyl) for use as photocrosslinkable extracellular matrix in Gelomics’ LunaGel™ 3D Tissue Culture System. GelMA is well-known as a biomaterial with unmatched tuneability and bioactivity in tissue engineering, 3D bioprinting, and 3D cell culture applications. The LunaGel™ X-Pure Photocrosslinkable Extracellular Matrix product series will be available as ready-to-use kits in low and high stiffness formulations, providing the first premium, ultrapure GelMA in an easy-to-use format.
Founded in 2018, Gelomics is rapidly growing to become a world-leading provider of fully integrated 3D cell, organoid, and tissue culture technologies that drastically improve the translational value of cell-based research and reduce the requirements for animal experimentation.
Gelomics‘ first products series LunaGel™ is a photocrosslinkable cell culture system that recreates the natural extracellular matrix (ECM) surrounding cells in the human body, allowing researchers to grow three-dimensional microscopic tissues, rather than just cells on plastic surfaces. The unique LunaGel™ photocrosslinking technology enables the rapid generation of highly biomimetic extracellular microenvironments with the largest range of mechanical tuneability on the market, enabling scientists to replicate the properties of various healthy and diseased tissues.
Learn more about Gelomics’ innovative products and access our product catalogue:
About Rousselot, Darling Ingredients' Health Brand
Launched in 2018, Rousselot Biomedical is Rousselot’s business segment specialized in superior biomedical gelatin and collagen solutions with ultra-low endotoxins level and ultra-high consistency levels supported by an expert team of biomedical engineers and doctors.
Offering unique advantages to assure performance, quality and safety from bench to clinic, Rousselot X-Pure® and Rousselot Quali-Pure® are backed by strong scientific data and on-going research. Rousselot Biomedical is committed to support end-to-end partnerships to help “Advancing medical science”.
Learn more about Rousselot Biomedical: www.rousselot.com/biomedical